DUMLU, R. Et Al. 2024. Ceftazidime-Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region. ANTIBIOTICS-BASEL , vol.13, no.10 .

DUMLU, R., ŞAHİN, M., Derin, O., Gul, O., Basgonul, S., Zengin, R., ... Arabaci, C.(2024). Ceftazidime-Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region. ANTIBIOTICS-BASEL , vol.13, no.10.

DUMLU, RIDVAN Et Al. "Ceftazidime-Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region," ANTIBIOTICS-BASEL , vol.13, no.10, 2024

DUMLU, RIDVAN Et Al. "Ceftazidime-Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region." ANTIBIOTICS-BASEL , vol.13, no.10, 2024

DUMLU, R. Et Al. (2024) . "Ceftazidime-Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region." ANTIBIOTICS-BASEL , vol.13, no.10.

@article{article, author={RIDVAN DUMLU Et Al. }, title={Ceftazidime-Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region}, journal={ANTIBIOTICS-BASEL}, year=2024}